
When CRO Selection Went Sideways, Ashvattha Therapeutics Did This To Recover
A conversation with Ashvattha Therapeutics CEO Jeff Cleland, Ph.D. Running a clinical trial is tough enough work. But complicate things with CRO troubles, a competitive therapeutic environment, and reluctant investigators, and you get a trial that’s …